Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
---|---|---|---|---|---|---|---|---|
MRK | MERCK & CO INC | United States | $258.25B | 2,534,809,312 | 76.95% | 0.20% | Net Buying | Net Buying |
LLY | ELI LILLY & CO | United States | $777.42B | 949,315,694 | 82.23% | 10.98% | Net Selling | Net Selling |
BIIB | BIOGEN INC | United States | $25.32B | 145,719,340 | 87.91% | 2.12% | Net Selling | Net Selling |
AZN | ASTRAZENECA PLC | United Kingdom | $221.40B | 1,550,000,000 | 32.15% | 0.00% | ||
JNJ | JOHNSON & JOHNSON | United States | $385.53B | 2,407,622,972 | 70.92% | 0.19% | Net Selling | Net Buying |
NVS | NOVARTIS AG | Switzerland | $218.62B | 1,999,300,000 | 6.90% | 0.00% | ||
SNY | SANOFI | France | $134.75B | 1,264,799,969 | 21.49% | 0.00% | ||
ABBV | ABBVIE INC | United States | $359.54B | 1,766,343,745 | 71.54% | 0.15% | Net Selling | Net Selling |
GSK | GSK PLC | United Kingdom | $74.77B | 4,055,000,000 | 7.78% | 0.00% | ||
AMGN | AMGEN INC | United States | $171.59B | 537,532,723 | 76.59% | 1.01% | Net Selling | |
GILD | GILEAD SCIENCES INC | United States | $111.44B | 1,244,992,081 | 83.19% | 1.09% | Net Selling | Net Selling |
GRFS | GRIFOLS SA | United States | $6.08B | 687,554,908 | 21.04% | 0.00% | ||
BMY | BRISTOL MYERS SQUIBB CO | United States | $110.17B | 2,028,176,674 | 75.57% | 0.36% | Net Selling | Net Selling |
PFE | PFIZER INC | United States | $159.18B | 5,666,695,064 | 65.94% | 0.27% | Net Selling | Net Selling |
OGN | ORGANON & CO | United States | $4.65B | 257,538,875 | 77.08% | 0.22% | Net Selling | Net Selling |
AMRN | AMARIN CORP PLC | Ireland | $241.04M | 411,338,131 | 18.91% | 15.44% | Net Selling | |
SCLX | SCILEX HOLDING CO | United States | $186.23M | 191,790,520 | 20.77% | 32.87% | Net Buying | Net Buying |
MIRA | MIRA PHARMACEUTICALS INC | United States | $28.08M | 14,780,885 | 4.82% | 30.32% | Net Selling | Net Selling |